Generic and biosimilar drugmaker Sandoz recently added a drug used in conjunction with cancer treatments to its list of drugs [...] …
Blog Posts
The federal office tasked with overseeing the 340B program will brief covered entities and manufacturers next week on the administrative [...] …
In last month’s column, I wrote about a reprehensible campaign by 340B opponents to tie this vital drug discount program [...] …
Mississippi this week became the fourth state to face a legal challenge to its 340B contract pharmacy law, when the [...] …
A major national 340B provider advocacy group is condemning the newly introduced 340B ACCESS Act, arguing that the proposed overhaul [...] …
Some long-time 340B advocates have warned that a new federal bill based on input from an alliance of the drug [...] …
SPONSORED CONTENT
Consolidated Service Centers (CSCs) centralize many pharmacy services along with the inventory of a health system and capture significant savings through processes such as strategic buys, standardization, and low units of measure distribution, just to name a few. But the most frequently asked question by
…
Maryland this week became the third state with a 340B contract pharmacy protection law to face a drugmaker lawsuit when [...] …
A fellow from a think tank that receives drug industry funding for its 340B work and a national leader for [...] …
![img](https://340breport.com/wp-content/uploads/2023/03/340B-expert-tip-logo-final.png)
SPONSORED CONTENT
![img](https://340breport.com/wp-content/uploads/2023/03/340B-expert-tip-sidearrow-logo-final.png)
TIP: Establishing controls and performing regular monitoring is crucial to prevent and identify noncompliance with 340B program requirements.
×
*Sign up for news summaries and alerts from 340B Report